Annual EBITDA
-$300.99M$72.62M+19.44%
Summary
- Current Value
- As of today, BNTX annual EBITDA is -$300.99M, up +19.44% on
- Historical Performance
- BNTX annual EBITDA is down -101.87% over the past 3 years, down -15.88% over the past 5 years
- All-Time High Comparison
- BNTX annual EBITDA is currently -101.44% below its historical high of $20.93B set on
- 3-Year Low Comparison
- BNTX annual EBITDA is +19.44% above its 3-year low of -$373.62M reached on
- Sector Comparison
- BNTX annual EBITDA is higher than 4.30% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$300.99M | +19.4% | -101.9% | -15.9% | – | |
| Quarterly EBITDA | -$631.53M | -19.0% | -178.8% | -133.5% | -3231.4% | |
| TTM EBITDA | -$383.90M | +1.0% | -104.4% | -123.9% | -1925.2% | |
| Price | $87.79 | -10.2% | -17.6% | -55.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $3.24B | +8.8% | -82.2% | +489.1% | – | |
| Annual EPS | -$5.30 | -77.2% | -113.4% | -7710.9% | – | |
| -$733.01M | -5.3% | -104.6% | -141.2% | – | ||
| Annual Net Income | -$1.28B | -78.2% | -112.9% | -7500.6% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $16.10B | N/A | -101.9% |
| 5Y | $20.93B | -101.4% | |
| All | $20.93B | -101.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$373.62M | +19.4% | |
| 5Y | -$373.62M | +19.4% | |
| All | -$373.62M | +19.4% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$300.99M | +19.4% | |
| -$373.62M | -131.7% | |
| $1.18B | -92.7% | |
| $16.10B | -23.1% | |
| $20.93B | +8,159.2% |
| Year | Value | Change |
|---|---|---|
| -$259.75M | -55.1% | |
| -$167.49M | -288.5% | |
| -$43.12M | +27.7% | |
| -$59.61M | - |
FAQ
What is the current annual EBITDA of BNTX?
As of today, BNTX annual EBITDA is -$300.99M
What is 1-year change in BNTX annual EBITDA?
BNTX annual EBITDA is up +19.44% year-over-year
What is 3-year change in BNTX annual EBITDA?
BNTX annual EBITDA is down -101.87% over the past 3 years
How far is BNTX annual EBITDA from its all-time high?
BNTX annual EBITDA is currently -101.44% below its historical high of $20.93B set on December 31, 2021
How does BNTX annual EBITDA rank versus sector peers?
BNTX annual EBITDA is higher than 4.30% of companies in Healthcare sector
When is BNTX next annual earnings release?
As of today, the next annual earnings release for BNTX has not been scheduled
Quarterly EBITDA
-$631.53M$552.38M-697.91%
Summary
- Current Value
- As of today, BNTX quarterly EBITDA is -$631.53M, down -697.91% on
- Historical Performance
- BNTX quarterly EBITDA is down -18.96% year-over-year, down -178.82% over the past 3 years
- All-Time High Comparison
- BNTX quarterly EBITDA is currently -111.76% below its historical high of $5.37B set on
- 3-Year Low Comparison
- BNTX quarterly EBITDA is +9.69% above its 3-year low of -$699.32M reached on
- Sector Comparison
- BNTX quarterly EBITDA is higher than 0.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$631.53M | -697.9% | -19.0% | -178.8% | -133.5% | |
| Annual EBITDA | -$300.99M | – | +19.4% | -101.9% | -15.9% | |
| TTM EBITDA | -$383.90M | -35.5% | +1.0% | -104.4% | -123.9% | |
| Price | $87.79 | -20.5% | -10.2% | -17.6% | -55.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $138.17M | -86.9% | -28.2% | -89.9% | -94.4% | |
| Quarterly EPS | -$2.46 | -69.9% | -35.1% | -211.9% | -146.5% | |
| -$773.44M | -185.4% | -34.3% | -200.8% | -141.4% | ||
| Quarterly Net Income | -$622.28M | -75.3% | -42.2% | -215.5% | -145.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $888.62M | -171.1% | |
| 3Y | $888.62M | -171.1% | |
| 5Y | $5.37B | -111.8% | |
| All | $5.37B | -111.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$631.53M | at low | |
| 3Y | -$699.32M | +9.7% | |
| 5Y | -$699.32M | +9.7% | |
| All | -$699.32M | +9.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of BNTX?
As of today, BNTX quarterly EBITDA is -$631.53M
What is BNTX quarterly EBITDA most recent change?
BNTX quarterly EBITDA was down -697.91% on March 31, 2026
What is 1-year change in BNTX quarterly EBITDA?
BNTX quarterly EBITDA is down -18.96% year-over-year
How far is BNTX quarterly EBITDA from its all-time high?
BNTX quarterly EBITDA is currently -111.76% below its historical high of $5.37B set on September 30, 2021
How does BNTX quarterly EBITDA rank versus sector peers?
BNTX quarterly EBITDA is higher than 0.18% of companies in Healthcare sector
When is BNTX next earnings release?
The next earnings release for BNTX is on
TTM EBITDA
-$383.90M$100.66M-35.54%
Summary
- Current Value
- As of today, BNTX TTM EBITDA is -$383.90M, down -35.54% on
- Historical Performance
- BNTX TTM EBITDA is up +1.00% year-over-year, down -104.44% over the past 3 years
- All-Time High Comparison
- BNTX TTM EBITDA is currently -101.84% below its historical high of $20.91B set on
- 3-Year Low Comparison
- BNTX TTM EBITDA is +1.00% above its 3-year low of -$387.78M reached on
- Sector Comparison
- BNTX TTM EBITDA is higher than 2.77% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$383.90M | -35.5% | +1.0% | -104.4% | -123.9% | |
| Annual EBITDA | -$300.99M | – | +19.4% | -101.9% | -15.9% | |
| Quarterly EBITDA | -$631.53M | -697.9% | -19.0% | -178.8% | -133.5% | |
| Price | $87.79 | -20.5% | -10.2% | -17.6% | -55.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $3.26B | -1.6% | +10.0% | -74.1% | +8.7% | |
| TTM EPS | -$5.87 | -12.2% | -70.9% | -123.0% | -203.9% | |
| -$920.58M | -27.3% | -29.3% | -110.8% | -159.1% | ||
| TTM Net Income | -$1.45B | -14.6% | -78.3% | -122.5% | -199.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $188.45M | -303.7% | |
| 3Y | $8.65B | N/A | -104.4% |
| 5Y | $20.91B | -101.8% | |
| All | $20.91B | -101.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$387.78M | N/A | +1.0% |
| 3Y | -$387.78M | +1.0% | |
| 5Y | -$387.78M | +1.0% | |
| All | -$406.63M | +5.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of BNTX?
As of today, BNTX TTM EBITDA is -$383.90M
What is BNTX TTM EBITDA most recent change?
BNTX TTM EBITDA was down -35.54% on March 31, 2026
What is 1-year change in BNTX TTM EBITDA?
BNTX TTM EBITDA is up +1.00% year-over-year
How far is BNTX TTM EBITDA from its all-time high?
BNTX TTM EBITDA is currently -101.84% below its historical high of $20.91B set on March 31, 2022
How does BNTX TTM EBITDA rank versus sector peers?
BNTX TTM EBITDA is higher than 2.77% of companies in Healthcare sector
When is BNTX next earnings release?
The next earnings release for BNTX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BNTX Official Website www.biontech.de
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776985/000177698526000017/0001776985-26-000017-index.htm
- BNTX Profile on Yahoo Finance finance.yahoo.com/quote/BNTX
- BNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bntx